BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32807513)

  • 1. An integrated approach to unravel a putative crosstalk network in Alzheimer's disease and Parkinson's disease.
    Bisht I; Ambasta RK; Kumar P
    Neuropeptides; 2020 Oct; 83():102078. PubMed ID: 32807513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating single-nucleus sequence profiling to reveal the transcriptional dynamics of Alzheimer's disease, Parkinson's disease, and multiple sclerosis.
    Fan LY; Yang J; Liu RY; Kong Y; Guo GY; Xu YM
    J Transl Med; 2023 Sep; 21(1):649. PubMed ID: 37735671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of candidate mRNAs and miRNAs as biomarkers for mild cognitive impairment and Alzheimer's disease.
    Qin H; Hu C; Zhao X; Tian M; Zhu B
    Int J Neurosci; 2023 Jan; 133(1):89-102. PubMed ID: 33541173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of public microarray data identifies biological regulatory networks in Parkinson's disease.
    Su L; Wang C; Zheng C; Wei H; Song X
    BMC Med Genomics; 2018 Apr; 11(1):40. PubMed ID: 29653596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Common Molecular Basis in Alzheimer's and Parkinson's Diseases.
    Rana P; Franco EF; Rao Y; Syed K; Barh D; Azevedo V; Ramos RTJ; Ghosh P
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-Wide Profiling of miRNA and mRNA Expression in Alzheimer's Disease.
    Chang WS; Wang YH; Zhu XT; Wu CJ
    Med Sci Monit; 2017 Jun; 23():2721-2731. PubMed ID: 28578378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F7, EREG, miR-451a and miR-106b-5p are associated with the cervical cancer development.
    Zong S; Liu X; Zhou N; Yue Y
    Arch Gynecol Obstet; 2019 Apr; 299(4):1089-1098. PubMed ID: 30607582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analysis of microRNA and gene expression profiles reveals a functional regulatory module associated with liver fibrosis.
    Chen W; Zhao W; Yang A; Xu A; Wang H; Cong M; Liu T; Wang P; You H
    Gene; 2017 Dec; 636():87-95. PubMed ID: 28919164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of molecular signatures and pathways to identify novel therapeutic targets in Alzheimer's disease: Insights from a systems biomedicine perspective.
    Rahman MR; Islam T; Zaman T; Shahjaman M; Karim MR; Huq F; Quinn JMW; Holsinger RMD; Gov E; Moni MA
    Genomics; 2020 Mar; 112(2):1290-1299. PubMed ID: 31377428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Related Network and Differential Expression Analyses Identify Nuclear Genes and Pathways in the Hippocampus of Alzheimer Disease.
    Quan X; Liang H; Chen Y; Qin Q; Wei Y; Liang Z
    Med Sci Monit; 2020 Jan; 26():e919311. PubMed ID: 31989994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of microRNA and Gene Expression Profiles in Alzheimer's Disease: A Meta-Analysis Approach.
    Moradifard S; Hoseinbeyki M; Ganji SM; Minuchehr Z
    Sci Rep; 2018 Mar; 8(1):4767. PubMed ID: 29555910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNAs Identify Shared Pathways in Alzheimer's and Parkinson's Diseases.
    Sadlon A; Takousis P; Alexopoulos P; Evangelou E; Prokopenko I; Perneczky R
    Trends Mol Med; 2019 Aug; 25(8):662-672. PubMed ID: 31221572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression meta-analysis of Parkinson's disease and its relationship with Alzheimer's disease.
    Kelly J; Moyeed R; Carroll C; Albani D; Li X
    Mol Brain; 2019 Feb; 12(1):16. PubMed ID: 30819229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shared Molecular Mechanisms between Alzheimer's Disease and Periodontitis Revealed by Transcriptomic Analysis.
    Jin J; Guang M; Ogbuehi AC; Li S; Zhang K; Ma Y; Acharya A; Guo B; Peng Z; Liu X; Deng Y; Fang Z; Zhu X; Hua S; Li C; Haak R; Ziebolz D; Schmalz G; Liu L; Xu B; Huang X
    Biomed Res Int; 2021; 2021():6633563. PubMed ID: 33869630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson's disease.
    Liu X; Chen J; Guan T; Yao H; Zhang W; Guan Z; Wang Y
    BMC Syst Biol; 2019 Jan; 13(1):10. PubMed ID: 30665415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the Molecular Mechanisms of Pterygium by Constructing lncRNA-miRNA-mRNA Regulatory Network.
    Xu N; Cui Y; Dong J; Huang L
    Invest Ophthalmol Vis Sci; 2020 Jul; 61(8):12. PubMed ID: 32645133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression Profiling of Blood microRNAs 885, 361, and 17 in the Patients with the Parkinson's disease: Integrating Interaction Data to Uncover the Possible Triggering Age-Related Mechanisms.
    Behbahanipour M; Peymani M; Salari M; Hashemi MS; Nasr-Esfahani MH; Ghaedi K
    Sci Rep; 2019 Sep; 9(1):13759. PubMed ID: 31551498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated microarray analysis provided a new insight of the pathogenesis of Parkinson's disease.
    Kong P; Lei P; Zhang S; Li D; Zhao J; Zhang B
    Neurosci Lett; 2018 Jan; 662():51-58. PubMed ID: 28965931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Integrated Network Analysis of mRNA and Gene Expression Profiles in Parkinson's Disease.
    Wang Y; Wang Z
    Med Sci Monit; 2020 Mar; 26():e920846. PubMed ID: 32210219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orchestration of a blood-derived and ADARB1-centred network in Alzheimer's and Parkinson's disease.
    Song Z; Ding Q; Yang Y
    Cell Signal; 2023 Oct; 110():110845. PubMed ID: 37544632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.